Prevalence of SARS-CoV-2 Antibodies among Federally Incarcerated Women
Description
In collaboration with Public Health Agency of Canada (PHAC) and the University of Ottawa, Correctional Service Canada (CSC) conducted the 2022 National Health Survey. One of the study objectives was to determine the prevalence of SARS-CoV-2 antibodies and whether they are derived from immunization or infection among federally incarcerated women.
Resources
| Name |
Format |
Description |
Link |
| Prevalence of SARS-CoV-2 Antibodies among Federally Incarcerated Women |
HTML |
|
https://www.canada.ca/en/correctional-service/corporate/library/research/research-brief/23-32.html |
| Prevalence of SARS-CoV-2 Antibodies among Federally Incarcerated Women |
HTML |
|
https://www.canada.ca/fr/service-correctionnel/organisation/bibliotheque/recherche/recherche-bref/23-32.html |